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Abstract
Background: Understanding the biological underpinnings of relapse in alcohol dependency is a major issue in
addiction research. Based on recent evidence regarding the relevance of occipital visual evoked response potentials
(ERPs) in addiction research, and its significance for relapse research, we assessed occipital ERPs to alcohol- and
non-alcohol-related stimuli in recently detoxified patients and controls.
Methods: Thirty recently detoxified patients with alcohol addiction, and 31 healthy control subjects, were assessed
in a Go and a NoGo condition, each using three visual stimuli: tea, juice and beer. In the “Go” condition, subjects
had to respond to the juice (12.5 %) and the beer stimulus (12.5 %), and ignore the tea picture (75 %). In the
“NoGo” condition, subjects had to respond to the tea picture (75 %) and ignore the juice and the beer picture
(12.5 % each). The subjects’ EEGs were analyzed with regard to the occipital P100 and N170 ERP components.
Patients were then evaluated for relapse 3 months after this initial assessment.
Results: P100 amplitudes differed between conditions and between stimuli, and we found a condition x electrode
interaction. However, none of these P100 results involved group or relapse-status effects. N170 amplitudes in
patients were elevated as compared to controls. Additionally, patients’ heightened N170 amplitudes in response to
the alcohol-related (beer) stimulus were found only under the NoGo condition, where subjects had to react to the
frequent tea stimulus and ignore the beer and the juice stimuli, thus resulting in a condition x stimulus x group
interaction. Patients reporting relapse in a 3-month follow-up assessment showed larger NoGo N170 alcohol
cue-related ERP amplitudes and increased depression scores as compared to patients who stayed abstinent.
Depression was related to shortened P100 latencies in patients, but unrelated to the N170 NoGo cue-reactivity effect.
Conclusions: Our results indicate a sensitivity of occipital ERPs to addiction-related stimuli when these act as
non-targets. Recently detoxified patients may be vulnerable to addiction-related cues when these occur outside the
focus of directed attention, thereby circumventing intentional control processes. Furthermore, ERPs to addiction-related
stimuli may be useful as a predictor of abstinence success in recently detoxified patients.
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Background
Alcohol use is among the most relevant risk factors
contributing to disease-related death and disability-
adjusted life years worldwide [1], with relapse predic-
tion being a major issue in the treatment of alcohol
use disorder [2, 3].
Investigations of brain responses to addiction-related
cues have emerged as a door to the assessment of
relapse behavior; and the incentive salience theory [4]
has been established as a major contribution providing a
theoretical framework for research into cue reactivity. A
major suggestion of this theory is that not only is the
drug associated with increased and persistent incentive
salience, but that drug-related cues and even drug-related
context signals elicit biased attention, trigger dopamine-
related reward systems and may lead to active drug
approach behavior, thus initiating relapse [5].
Studies on cue reactivity have measured altered periph-
eral physiological signals [6], evoked response potential
(ERP) data derived from EEGs [7, 8] and neuroimaging
brain activation changes [9] to drug- related cues. Carter
and Tiffany (1999), for example, analyzed more than 40
studies measuring cue- related changes in physiological
signals [6]. With regard to alcohol addiction, they reported
a medium effect size of d = .53 for the induction of crav-
ing, and of d = .39 for increases in heart rate with exposure
to addiction-related stimuli. With regard to ERP research,
Littel et al. [7] reviewed studies which focused on slow
wave potentials and the P300 ERP component, which are
usually measured at the frontal to parietal electrode sites.
Patients with substance abuse disorders showed height-
ened P300 and slow wave amplitudes in reaction to drug-
related stimuli [10–12]. These results are of importance
since exaggerated ERP amplitudes to drug cues have been
associated with relapse behavior. For example, Petit and
colleagues [12] recently found that P300 oddball task
parameters in response to alcohol stimuli are related to
successful 3-month abstinence in detoxified alcohol
dependent patients. In this study, 3 month successful
alcohol abstinence was associated with reduced P300
amplitudes in response to addiction-related stimuli as
compared to patients relapsing within the 3 month evalu-
ation period, indicating the relevance of evoked potential
measures as probable indicators of treatment success.
Expanding upon this more traditional approach to
ERP research in alcohol use disorders, Maurage and
colleagues established the assessment of occipital evoked
potential components which allows the evaluation of
early visual processing in research on alcohol use disor-
ders [13–15]. The occipital positive P100 component
indexes early visual processing, and its amplitude is
more closely confined to the perceptual properties of the
stimulus as compared to the negative N170 component,
which has been widely studied with regard to face
processing [16, 17]. In a recent meta-analysis on studies
assessing the N170 in the context of face processing, the
authors not only found that this component is sensitive
to emotional expressions, but also that the N170 was
modulated in amplitude when the attention of subjects
was directed to non-face-related visual target features
[18]. In another study by Hietanen & Nummenmaa [19],
authors reported evidence that affective arousal elicited
by naked body stimuli significantly enhanced N170
amplitudes, and Tanaka & Curran [20] reported differen-
tially enhanced N170 amplitudes in dog and cat experts
when shown stimuli related to their area of expertise,
indicating that non-face stimuli may contribute to the
amplitudes of the occipital N170 component.
In line with the research focus on the N170 component
in face processing experiments, Maurage [14] assessed
emotional face processing and reported prolonged P100
and N170 latencies, and lower N170 amplitudes, in
recently detoxified alcohol-dependent patients. Early
visual processing abnormalities with respect to face stim-
uli were replicated in alcohol dependent patients and in
binge drinkers [13, 21]. Although these studies targeted
aspects of visual face processing in general, and not
addiction-specific cue reactivity, they demonstrated that it
is worthwhile to study occipital processing in experiments
on stimulus processing in addicted individuals. This is
further supported by a recent study by Petit et al. [15]
reporting increased occipital P100 amplitudes in binge
drinkers in response to rare alcohol-related target stimuli
as compared to non-alcohol-related target stimuli, indicat-
ing that these stimuli influence the very early stages of
cortical processing in subjects prone to develop alcohol
addiction. Taken together, these studies support the idea
that, with respect to the occipital P100 and N170 compo-
nents, alcohol-related stimuli may be processed differently
from non-alcohol-related stimuli, when they act as targets.
Due to their probable specific significance for addicted
patients, and in accordance with the results of Hinojosa et
al. [18] and Hietanen et al. [19] on non-face stimulus char-
acteristics affecting the N170 component, this may even
occur when drug related stimuli are presented as non-
target stimuli.
In the present study, we aimed to investigate the P100
and N170 components of early occipital visual processing
in response to alcohol and non-alcohol-related pictures in
recently detoxified alcohol dependent patients. We ap-
plied a conventional oddball paradigm using a frequently
presented non-alcohol-related and non-target stimulus
(tea) in combination with non-alcohol (orange juice) and
alcohol-related target stimuli (beer, Go-condition). In a
second part of the experiment, the tea stimulus acted as a
target, and the same two less frequently presented stimuli
acted as to-be-ignored non-target stimuli (NoGo condi-
tion). In addition, we examined the relation between these
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parameters and patients’ 3-month relapse status. Based on
existing evidence, and given the specific significance of
alcohol-related stimuli to alcohol-dependent patients, we
expected heightened occipital P100 and N170 amplitudes
in patients, but not controls, in response to drug-related
stimuli, specifically when such stimuli act as targets, and
perhaps even when attention is focused on non-drug stim-
uli. Successful 3-month abstinence may be associated with
lowered ERP amplitudes when taking into consideration
the results of Petit et al. [12].
Methods
Subjects
We assessed 30 patients with alcohol dependence and
31 control subjects. All subjects gave written informed
consent before participation in the study. The study was
approved by the ethics committee of the faculty of medicine
of the University of Duisburg-Essen.
Participating patients had recently successfully com-
pleted an inpatient detoxification treatment program in
a specialized hospital ward for addictive disorders.
Symptoms of alcohol withdrawal were alleviated by
temporary administration of clonazepam or clomethia-
zole, respectively, according to the German treatment
guidelines regarding the detoxification of alcohol addicts
[22]. Medication dosage was based on the monitoring of
withdrawal intensity by a symptom checklist.
The inclusion criteria for patients were alcohol depend-
ency (DSM-IV 303.9), and age (between 18 and 60 years).
Exclusion criteria were use of psychotropic medication
and sedatives (e.g. benzodiazepines, antidepressant medi-
cation) other than zopiclone, a history or presence of
substance abuse or dependency other than alcohol (apart
from nicotine), uncorrected vision problems, and major
psychiatric axis-I co-morbidity (e.g. schizophrenia, major
depression). The one inclusion criterion for controls was
age (between 18 and 60 years). Exclusion criteria were
present or past substance dependency (apart from nico-
tine), major psychiatric disorders (e.g. schizophrenia or
major depression), any psychotropic medication, and
uncorrected vision problems. Controls received 40
Euros in exchange for their participation in the study.
Controls were recruited through local advertisement
and were matched for patients’ age, gender and level of
education Table 1.
Clinical assessments
In order to verify inclusion and exclusion criteria, patients
and controls were assessed using the structured interview
for DSM-IV criteria, the Mini-International Neuropsychi-
atric Interview [23]. The substance dependency-related
scales used in this study were the Alcohol Use Disorders
Identification Test [24], the German version of the Obses-
sive Compulsive Drinking Scale [25], the Fagerström Scale
for Nicotine dependency [26] and the European Addiction
Severity Index [27]. In order to assess additional symptom
dimensions, all subjects completed the self-rating scales
set forth in the Beck Depression Inventory [28] and the
Barratt Impulsivity Scale [11, 29].
For patients receiving clomethiazole (elimination half-
life 3–5 h) at least 24 h had elapsed between the last
administration and the EEG assessment. Patients treated
with clonazepam were scheduled for the EEG assess-
ment as soon as they reached an estimated plasma level
of < .05 mg/l, in accordance with its elimination half-life
of 40 h and 1 day additional wash-out time [30]. Two
patients received zopiclone the night before the assess-
ment. With a half-life of 5 h, and the assessments taking
Table 1 Subject characteristics: patients and control subjects
Control (n = 31) Patient (n = 30) p =
Age y (std) 43.3 (9.0) 44.3 (8.0) .56 (ANOVA)
Handedness (n, right) 29 29 .57 (Chi2)
Gender (n: f/m) 6/25 5/25 .79 (Chi2)
Nicotine dependency (n) 16 23 .02 (Chi2)
Fagerström Score mean (sd) 2.55 (3.0) 5.63 (3.9) .001(ANOVA)
School (n:without/low/mid/high*): 0,9,10,12 1,14,6,9 .32 (Chi2)
Preference drink (n:beer/wine/other) 19/6/5 20/6/4 .85 (Chi2)
Health-related problems (n) 1.48 (5.60) 9.00 (13.14) .005 (ANOVA)
Breath alcohol concentration in per mille (sd)** - 1.15 (1.30) -
AUDIT mean (std) 2.71 (1.83) 24.50 (7.71) <.001 (ANOVA)
OCDS-G Score mean (sd) 1.39 (1.43) 18.9 (7.18) <.001 (ANOVA)
BDI mean (sd) 3.23 (4.13) 14.17 (8.67) <.001 (ANOVA)
Barratt Impulsivity Scale total score mean(sd) 42.58 (3.93) 44.36 (3.37) .06 (ANOVA)
*School education level: none = no formal school certificate, low = 9 to 10 years German basic school level “Hauptschule”, mid = 10 years German mid level
“Realschule”, high = 12 to 13 years German high level “Gesamtschule” or “Gymnasium” **at start of hospitalization
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place at more than 2.5 half-life, we do not expect this to
have affected our results [31]. EEG and clinical assess-
ments were conducted at least 10 days after the start of
alcohol detoxification.
Three months after the EEG assessment, patients
were re-contacted in a telephone survey inquiring as
to whether or not they continued to be abstinent.
Interviews were conducted by a physician (CMR)
known to the patients from their time at the hospital,
and the occurrence of a relapse was determined based
on the information given by the patients during the
interview. A relapse was diagnosed when patients
reported a return to alcohol consumption rates at or
near the level of their pre-detoxification use. The
telephone survey did not include additional physical
or psychological investigations.
EEG and event-related potential task
The EEG assessments were conducted with subjects
seated in a reclining chair in an electrically shielded
room. The assessment was split into four runs of about
13 min each. Subjects with nicotine dependency were
asked if they craved nicotine, and allowed to smoke
following the first two runs in order to minimize the
effects of acute nicotine deprivation on the EEG signals.
Subjects were presented with three stimuli which
depicted either three freshly drawn glasses of beer, an
ensemble of a mug and a glass of orange juice or a cup
of tea with the tea bag just being withdrawn. All three
stimuli were licensed from a provider of professional
food images (stockfood.de) for use as stimuli in research,
and adjusted to match each other in hue and luminance.
Stimuli were selected from among a variety of images
via a pre-study in which 20 alcohol dependent patients
rated the images based on popularity and craving poten-
tial. Among alcohol-related stimuli it turned out that
beer scored the highest in popularity, followed by vodka
and wine. Beer pictures which patients associated with
brands from southern Germany scored low in popularity,
and were therefore not taken into consideration. In select-
ing the neutral tea and juice stimuli it proved to be of
relevance not to choose stimuli which patients may associ-
ate with alcoholic drinks. The selected pctures may be
looked up and viewed by their reference numbers at
stockfood.de; tea: 277227, orange juice: 00647384, beer:
00057014 (Fig. 1).
In each of the two experimental task conditions, 624
pictures were presented on a 14 in. computer monitor in
pseudo-randomized order in two runs of 312 pictures
each, for a duration of 500 ms per picture, with a
2500 ms inter-stimulus interval (+/- 500 ms). In the Go
condition, subjects had to press a button with their right
index finger upon appearance of the beer (N = 2 × 31,
12.5 %) and orange juice (N = 2 × 31, 12.5 %) stimuli,
and had to ignore the frequent tea stimuli (N = 2 × 250,
75 %). In the NoGo condition, subjects had to press a
button with their right index finger upon appearance of
the frequent tea stimulus, and had to ignore the rare
beer and orange juice stimuli. All stimuli were presented
using Presentation software (Neurobehavioral Systems
Inc.). In the Go condition, subjects were instructed to
“please press the button whenever and only when you
see the beer or the orange juice picture. Please ignore
the tea picture”. In the NoGo condition, subjects were
instructed to “please press a button whenever and only
when you see the tea picture. Please ignore the beer and
the juice pictures.” In subjects with a high amount of
artifacts during data acquisition, additional runs were
conducted in order to ensure that a sufficient amount of
segments entered the single subject averages. This had
to be done for six control subjects and three patients.
Each subject’s EEG was recorded using a 32 channel
electrode cap with tin electrodes positioned according
to the extended 10/20 system, with electrodes refer-
enced to linked earlobes and two bipolar channels
used to monitor horizontal and vertical eye move-
ments. EEG data were amplified using a 32 channel
Neuroscan Synamps amplifier in the frequency range
of 0.03 Hz to 30 Hz at a sampling rate of 100 Hz.
Electrode impedances were kept < 5 kΩ. EEG data
analysis was performed using Neuroscan Edit (v4.2)
and Brain Vision Analyzer (V1.05) software.
The EEG data were screened for sequences contain-
ing complex artifacts (i.e. clenching teeth or swallow-
ing) which were then excluded from further analysis.
Blink artifacts were corrected using the method
described by Semlitsch [32], as implemented in Scan
V.4.2 software. Data were segmented into intervals
Fig. 1 Visual stimuli showing the beer, the juice and the tea stimuli
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ranging between -100 ms and 1000 ms relative to
stimulus onsets for segments with valid behavioral
data. Segments were corrected for the -100 ms to
0 ms baseline interval, and segments exceeding +/- 50 μV
shifts in EEG data were excluded from further analysis.
Single subject averages were computed separately for
stimulus categories and conditions.
Here we report data from electrodes O1 and O2.
Single subject average curves were analyzed for event-
related components P100 and N170 amplitudes. The
mean number of segments in averages ranged between
322 (sd = 94.2, Go condition, patients) and 370 (sd = 84.7,
tea, Go condition, controls) for the frequent tea stimulus,
and 34 (sd = 8.5, beer, NoGo condition, patients) and 46
(sd = 11.1, juice, Go condition, controls) for the infrequent
beer and juice stimuli.
Data analysis
Behavioral data were analyzed with regard to error
percent data for each stimulus under both task condi-
tions using t-statistics. Amplitudes and latencies of P100
and N170 components at electrodes O1 and O2 were
analyzed using repeated measurement MANOVAs with
group (patients/controls) as between factor and elec-
trode (O1, O2), stimulus (tea, orange juice, beer) and
condition (Go [press for tea], NoGo [press for orange
juice and beer]) as within factors. Statistical analyses
were computed using statistical software SPSS V.22
(IBM Corp., New York). Analyses of ERPs comparing
relapsing and non-relapsing patients were conducted
separately for the two conditions as group (between
factor: with/without relapse), by electrode (within factor:
O1, O2) and by stimulus (within factor: tea, orange juice,
beer) MANOVAs in order to reduce the complexity of
analyses comparing groups with low numbers of subjects.
MANOVA results are reported for within-subjects multi-
variate tests with Greenhouse-Geisser adjusted p-values.
BDI scores were introduced as covariate in additional
MANCOVA analyses in order to explore the influence of
depression on ERP results.
Results
Subject characteristics
Details of subject characteristics are given in Table 1.
Patients and controls did not differ with regard to age,
gender, education or handedness. Mean breath alcohol
concentration at hospitalization was 1.15 1 per mille
(SD = 1.3), and mean years of alcohol dependency was
12 years (SD = 8). The mean number of previous in-
patient detoxification treatments among patients was
4.9. On questionnaires and in interviews, patients
scored higher than controls in terms of smoking,
alcohol use, compulsive drinking and depression
symptoms, but not in in terms of impulsivity as
measured by the Barratt Impulsivity Scale. Relapse
assessment was successfully achieved in 23 out of 30
patients. Eleven patients remained abstinent from
alcohol and 12 patients relapsed within the 3-month
evaluation period.
Behavioral results
With regard to the Go and NoGo conditions, the amount
of errors was slightly larger for patients under both condi-
tions. Differences between patients and controls, however,
failed to reach the level of statistical significance under
both conditions and all three stimuli. A table on perform-
ance data is given in Table 2.
ERP results
ERP grand average curves for patients and controls are
given in Fig. 2. Figure 3 shows amplitudes of the N170
component in patients and controls, and for relapsing and
non-relapsing patients. The means and standard
deviations of the occipital P100 and N170 component
amplitudes and latencies are reported in Table 3. Details
on analysis of variance and covariance results may be
found in the Additional file 1.
Patient vs. control
P100 and N170 latencies
An analysis of latencies in two stimulus type (within factor:
Tea, Juice, Beer) x condition (within factor: Go, NoGo)
x electrode (within factor: O1,O2) x group (between
factor: patients, controls) MANOVAs for the P100 and
the N170 components yielded no significant results.
P100 amplitudes
With regard to P100 amplitudes, we found a condition
(Go/NoGo) main effect (F(1,58) = 7.8, p = .007), a main
effect for stimulus type (tea, juice,beer: F(1.8,104.9) = 41.1,
p < .001) and a stimulus x electrode interaction (F(1.9,109.4)
= 6.4, p = .003). P100 amplitudes were larger in the NoGo
as compared to the Go condition. The juice stimulus
showed lower amplitudes as compared to the tea and beer
stimuli, regardless of condition and group. O1 electrode
amplitudes were larger than O2 amplitudes for tea and
beer but not for the juice stimuli. For P100 amplitudes we
found no results involving the group factor.
Table 2 Behavioral data
Condition Stimulus Patient m (sd) Control m (sd)
Go (% errors) Tea (non-target) 9.42 (9.93) 6.78 (6.19)
Beer (target) 5.32 (6.30) 4.71 (6.97)
Juice (target) 10.70 (8.10) 8.93 (6.18)
NoGo (% errors) Tea (target) 6.59 (7.05) 7.09 (5.91)
Beer (non-target) 24.79 (15.08) 22.46 (13.06)
Juice (non-target) 17.04 (12.03) 13.38 (10.20)
Matheus-Roth et al. BMC Psychiatry  (2016) 16:74 Page 5 of 12
Fig. 2 Grand averages of event-related responses in patients and controls to tea, orange juice and beer stimuli (a) in the Go and (b) the NoGo
condition at occipital electrodes O1 and O2
Fig. 3 Mean and standard errors of the N170 component amplitudes of event-related responses to tea, orange juice and beer stimuli in the Go
and NoGo condition at occipital electrodes O1 and O2 for patients and controls (a) and for patients with and without 3-months relapse (b)
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N170 amplitudes
With N170 amplitudes we found a main effect for group
(patients, controls: F(1,58) = 7.3, p = .009), a main effect for
stimuli (tea, juice, beer, F(1.9,113.9) = 6.3, p = .003) and a
three-way condition (go/nogo) x stimulus type (tea, juice,
beer) x group (patients, control) interaction (F(1.8,106.5) = 4.0,
p = .024). N170 amplitudes were larger (i.e. more negative)
in patients as compared to controls. The beer stimulus
resulted in more negative amplitudes as compared to the
tea and juice stimuli. The three-way interaction of within
factor condition (Go/NoGo) x within factor stimulus type
(tea, juice, beer) x between factor group (patient, control)
was attributable to larger beer stimulus amplitudes in
patients as compared to controls—and more so in the
NoGo as compared to the Go condition—indicating larger
(i.e. more negative) beer stimulus amplitudes when patients
had to react to the tea and ignore the beer and juice stimuli.
Significant effects related to group were further examined
under separate analyses for each task condition with two
within factor stimulus type (tea, juice, beer) x between
factor group (patient, control) MANOVAs for the Go and
the NoGo condition. The main effect of group with height-
ened amplitudes in patients remained statistically signifi-
cant in both conditions (Go F(1,59) = 7.4, p = .008; NoGo
F(1,58) = 6.0, p = .017). Upon closer examination of the
three-way interaction involving the group factor with these
two MANOVA analyses conducted separately for the Go
and the NoGo condition, the stimulus type x group
interaction in the Go condition for the N170 compo-
nent was not significant (F(1.8,108.9) = 0.79, p = .445)
whereas the interaction was still significant in the
NoGo condition (F(1.9,112.5) = 4.2, p = .018). Therefore,
the effect of heightened N170 amplitudes in response
to the beer stimulus in the patients as compared to
controls was attributable to the NoGo condition,
where subjects had to react to the tea and ignore the
juice and beer stimuli.
Depression as a covariate
Since depression symptoms may act as a confounding
variable, we conducted additional analyses of variance,
replicating previous analyses which included Beck De-
pression Inventory scores as covariate. For the P100
amplitudes in the between factor group (patient/control)
x within factor condition (Go/NoGo) x within factor
stimulus type (tea/juice/beer) x within factor electrode
(O1/O2) MANCOVA with BDI scores as covariate, we
replicated the main effects of stimulus and condition but
not the stimulus x electrode interaction. No other effects
were statistically significant. With P100 latencies we
found a stimulus x electrode x BDI score interaction
(F1,71; 97.29 = 3.70, p = .035). While P100 latencies may
vary with different stimuli at the two occipital electrodes
with depression scores, this effect is unrelated to alcohol
addiction in our study.
With N170 amplitudes and BDI scores as covariate in
the MANCOVA analysis, we replicated the main effect
for group. The main effect for stimulus type, however,
was no longer significant. The three-way interaction of
group x stimulus type x condition was still significant
(F1.84; 104.75 = 3.63, p = .034). No other effects were sta-
tistically significant. Our follow-up analysis of the the
significant three-way interaction effect in N170 latencies
in the Go and the NoGo conditions separately in group
x electrode x stimulus MANCOVA analyses with BDI as
covariate, replicated the main effect for group only in
the Go condition. No effects involving the BDI scores
were found. The stimulus type x group interaction in
Table 3 P100 and N170 component amplitudes and latencies of patients and controls
Amplitude (mean/sd, μV) Latency (mean/sd, ms)
Control Patient Control Patient
O1 O2 O1 O2 O1 O2 O1 O2
p100 go beer 6.52 (4.42) 6.01 (4.35) 6.24 (3.70) 5.35 (3.70) 96.67 (13.42) 97.87 (18.90) 95.33 (11.96) 95.93 (11.55)
go juice 4.82 (3.84) 4.58 (3.82) 4.35 (3.40) 4.19 (3.50) 100.47 (19.59) 99.87 (20.05) 100.73 (18.43) 95.87 (16.34)
go tea 7.06 (4.49) 6.14 (4.12) 6.09 (3.64) 5.71 (3.50) 95.60 (19.44) 98.93 (11.93) 96.47 (10.34) 96.27 (10.76)
no go beer 7.24 (4.77) 6.77 (4.32) 7.02 (3.78) 6.44 (3.57) 99.27 (14.14) 98.60 (11.99) 96.60 (12.14) 97.20 (13.44)
no go juice 5.39 (3.32) 5.23 (3.15) 4.37 (3.40) 4.42 (3.12) 97.47 (23.00) 100.07 (17.62) 102.00 (19.87) 101.73 (18.91)
no go tea 8.24 (5.60) 7.12 (5.06) 6.80 (3.84) 6.34 (3.96) 98.07 (14.57) 97.13 (11.72) 98.80 (10.75) 97.40 (15.82)
n170 go beer −3.38 (3.60) −3.37 (3.44) −5.78 (4.92) −6.44 (5.54) 153.80 (20.56) 148.73 (19.27) 152.27 (33.61) 147.53 (18.71)
go juice −2.18 (3.64) −2.30 (3.38) −5.27 (5.11) −4.99 (5.29) 147.60 (27.78) 149.73 (32.51) 148.40 (28.50) 144.13 (31.09)
go tea −2.82 (3.20) −2.76 (3.17) −4.93 (4.04) −4.67 (4.14) 145.20 (18.75) 149.87 (13.74) 147.53 (17.48) 147.13 (17.54)
no go beer −3.03 (3.74) −2.94 (3.73) −6.41 (5.47) −6.31 (5.54) 148.07 (19.01) 146.20 (17.54) 149.40 (20.50) 150.00 (20.91)
no go juice −3.39 (3.17) −3.11 (3.03) −4.72 (4.44) −4.56 (4.83) 148.53 (24.77) 146.53 (21.85) 155.07 (30.37) 155.53 (30.22)
no go tea −2.77 (3.82) −2.61 (2.95) −5.01 (4.35) −4.66 (4.45) 148.93 (14.99) 146.93 (22.11) 150.53 (16.71) 146.67 (24.63)
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the NoGo condition was not replicated in the BDI
covariance analysis. With N170 latencies we found no
effects in the additional BDI covariance analyses.
Relapse assessment
Patients with (n = 12) and without (n = 11) 3-month re-
lapse did not differ with regard to age, gender, education
or preferred form of alcohol consumption. Additionally,
they did not differ in clinical scales (Fagerström, AUDIT,
OCDS-G, ASI, MINI, BIS), apart from the Beck Depres-
sion Inventory (BDI). When measured at the time of the
EEG assessment, patients who stayed abstinent over the
next 3 months scored 9.0 (sd = 7.4) BDI points versus
18.3 (sd = 6.5) points in patients who relapsed. Details
on subject characteristics and ERPs in relapsing and
non-relapsing patients are given in Table 4.
Figure 3 shows ERP grand average curves of relapsing
and non-relapsing patients with regard to the occipital
P100 and N170 components. The P100 and N170 ERP
component amplitudes and latencies were submitted to
separate MANOVAs with condition (Go/NoGo) and
electrode (O1/O2) as within factors and group (relapse/
non relapse) as between factor in the 23 patients which
were successfully interviewed 3 months following the
initial assessments. No significant effects emerged for
the analysis of P100 and N170 latencies.
In the between factor group (relapse/abstinence) x within
factor stimulus (tea, juice beer) x within factor electrode
(O1/O2) MANOVAs of P100 amplitudes in the Go and the
NoGo condition separately, we found a main effect for
stimuli but no effect related to relapse status. Juice
stimuli were associated with larger amplitudes in the
Go (F(1.9,39.9) = 11.2, p < .001) and the NoGo condition
(F(1.7,36.0) = 12.3, p < .001). In the analysis of N170 ampli-
tudes in a between group (relapse/abstinence) x within
stimulus (tea, juice, beer) x within electrode (O1/O2)
MANOVAs separately for the Go and the NoGo condition
we found a main effect for stimuli only in the NoGo
condition (F(1.8,39.1) = 7.4, p = .002). This effect was attrib-
utable to heightened beer stimulus amplitudes. Addition-
ally, we found a stimulus x group interaction in the NoGo
condition with heightened amplitudes in response to the
beer stimulus in patients who relapsed during the 3-month
evaluation period (F(1.9,39.2) =4.6 p = .018). Details of ampli-
tudes and latencies for relapsing and non-relapsing patients
are given in Table 5.
Depression as a covariate in relapse assessment
Since depression symptoms may act as a confounding
variable, we conducted additional MANCOVA analyses,
replicating previous analyses which included Beck De-
pression Inventory scores as covariate. For the P100
amplitudes in the between factor group (with/without
relapse) x within factor stimulus type (tea/juice/beer) x
within factor electrode (O1/O2) MANCOVAs with BDI
scores as covariate in the Go and the NoGo condition
separately, we found main effects for group in both con-
ditions. Additionally, we found main effects for the BDI
scores in both analyses. Heightened BDI scores tended
to be associated with shorter P100 latencies in the Go as
well as in the NoGo condition. Introduction of the BDI
covariate revealed a relapse group main effect. Relapsing
patients showed longer P100 latencies when BDI acted
as covariate (P100 Go condition: depression main effect
F[1, 20] = 10.48, p = .004; P100 NoGo condition: depres-
sion main effect F[1, 20] = 7.44, p = .013).
Table 4 Subject characteristics: patients with and without relapse
Without relapse (n = 11) With relapse (n = 12) p =
Age y(std) 48.27 (8.67) 42.17 (7.60) .086 (ANOVA)
Handedness (n, right) 11/11 12/12 n.a.
Gender (n: f/m) 2/9 9/9 .545 (Chi2)
Nicotine dependency (n) 7 11 .131 (Chi2)
Fagerström Score mean (sd) 5.00 (4.17) 6.67 (3.37) .302(ANOVA)
School (n:without/low/mid/high*): 0,5,2,4 1,5,2,4 .811 (Chi2)
Preference drink (n:beer/wine/other) 6/3/2 10/1/1 .318 (Chi2)
Health-related problems (n) 14 (15.36) 9 (12.95) .445 (ANOVA)
Breath alcohol concentration in per mille (sd)** 0.47 (0.60) 1.36 (1.34) .055 (ANOVA)
AUDIT mean (sd) 20.82 (6.11) 24.92 (5.74) .174 (ANOVA)
OCDS-G Score mean (sd) 16.45 (8.65) 20.33 (5.74) .215 (ANOVA)
BDI mean (sd) 9.00 (7.43) 18.25 (6.45) .004* (ANOVA)
Barratt Impulsivity Scale total score mean (sd) 66.27 (4.92) 66.58 (3.80) .866 (ANOVA)
Previous detoxifications, mean (sd) 1.55 (1.51) 7.17 (8.91) .052 (ANOVA)
*School education level: none = no formal school certificate, low = 9 to 10 years German basic school level “Hauptschule”, mid = 10 years German mid level
“Realschule”, high = 12 to 13 years German high level “Gesamtschule” or “Gymnasium” **at start of hospitalization
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Discussion
The main finding of the present study is that occipital
N170 amplitudes in response to the addiction-related
beer stimulus were elevated in recently detoxified pa-
tients with alcohol dependence when the stimulus had
to be ignored and attention was focused on the non-
addiction-related tea stimulus. The specificity of this
result is further supported by the fact that the increase
in amplitude did not occur to the same extent under the
other to-be-ignored NoGo stimulus, i.e. the juice picture
in our experiment. To our knowledge, this effect has not
been reported previously. The relevance of this finding
for relapses in patients is supported by our second major
finding. Patients who relapsed in the 3 months following
detoxification had larger occipital NoGo N170 ampli-
tudes in response to the alcohol- related stimulus as
compared to those who remained abstinent at the time
of the EEG assessment.
This latter result is in line with recently published
evidence by Petit et al. [12], who reported lowered ERP
amplitudes to be related to successful 3-month abstinence
among recently detoxified alcohol addicts. Although Petit
et al. based their results on parameters which substantially
differ from those applied in our study, both studies imply
that a lower reactivity to addiction-related stimuli is corre-
lated with abstinence success.
EEG studies exploring cue reactivity have mainly fo-
cused on ERP components with peaks at frontal to parietal
sites, such as the P300 component. P300 amplitudes show
larger amplitudes in response to addiction-related cues
[10, 33], but have only rarely been investigated at occipital
electrodes or related to visual processing of the P100 com-
ponent [34]. It is of interest to note that the study by
Bloom et al. [33] reported increased amplitudes only to
target stimuli which elicit the P300 component, but not to
non-target stimuli in their experiment. When considering
the relevance of electro-cortical responses to NoGo
stimuli, these are usually investigated in tasks targeting
frontal control processes, for example in experiments on
the NoGo-anteriorisation effect studied by the Fallgatter
group (i.e. [35]).
Maurage et al. [13, 14] studied stimulus processing in
alcohol dependent subjects by analyzing the occipital
N170 component in response to emotional face stimuli,
and found increased latencies and reduced amplitudes in
patients. Here, we found prolonged P100 latencies only
in the relapse assessment and when the effect of depres-
sion was controlled for in the covariance analyses. While
this effect was not seen in the covariance analyses
comparing patients and controls, it may be attributable
to the group of the more severely affected patients who
relapsed within 3 month following detoxification. Condi-
tion and stimulus-related P100 amplitude main effects
may be attributable to physical aspects of the stimuli,
which are unrelated to the group factor. With regard to
the N170 component, our study, however, does not
replicate latency differences, and amplitudes are not
diminished in the processing of visual stimuli in our
patients, but rather heightened in the N170 component
amplitudes, and significantly so, with the to-be-ignored
NoGo beer stimulus. This may indicate a specific sensi-
tivity of occipital cortical reactions to NoGo stimuli
which previous research focusing on frontal control
processes associated with response inhibition to rare
stimuli may have overlooked.
The experimental design of our study controlled for
the condition relevance and addiction relevance of the
stimuli by requiring subjects to press a button either
Table 5 P100 and N170 component amplitudes and latencies of patients with and without relapse n = 23
Amplitude (mean/sd, μV) Latency (mean/sd, ms)
Without relapse With relapse Without relapse With relapse
O1 O2 O1 O2 O1 O2 O1 O2
p100 go beer 5.53 (3.25) 4.40 (2.94) 7.96 (4.10) 7.10 (4.52) 96.18 (8.60) 95.64 (8.98) 101.00 (8.76) 100.67 (10.93)
go juice 3.63 (3.00) 3.45 (2.78) 5.78 (3.97) 5.63 (4.49) 110.36 (14.47) 97.45 (18.40) 100.50 (17.38) 96.00 (16.45)
go tea 5.36 (4.16) 5.07 (3.87) 7.27 (3.97) 6.89 (3.89) 92.91 (12.28) 94.00 (13.11) 100.00 (8.78) 110.36 (14.47)
no go beer 7.12 (3.33) 5.98 (3.32) 7.84 (4.81) 7.53(4.46) 94.36 (11.86) 96.54 (17.98) 101.33 (11.45) 100.33 (11.63)
no go juice 4.30 (3.93) 3.77 (3.08) 5.25 (3.10) 5.58 (3.58) 99.09 (22.63) 98.18 (20.03) 106.17 (14.86) 102.67 (20.70)
no go tea 6.01 (4.20) 5.19 (4.14) 8.16 (4.15) 7.68 (4.61) 98.18 (12.63) 94.91 (10.86) 101.67 (11.24) 100.00 (22.53)
n170 go beer −5.39 (3.66) −6.02 (4.73) −7.00 (6.18) −7.01 (6.54) 169.45 (41.78) 146.55 (14.56) 149.83 (13.66) 150.83 (10.63)
go juice −6.08 (6.01) −7.01 (5.65) −4.46 (5.62) −5.00 (5.23) 164.55 (23.22) 158.18 (29.78) 144.00 (22.95) 136.67 (26.00)
go tea −5.07 (3.85) −5.34 (3.47) −4.75 (4.75) −4,31 (5.40) 146.91 (23.07) 148.55 (23.27) 146.50 (10.17) 146.33 (9.79)
no go beer −5.05 (5.20) −5.63 (4.87) −7.58 (5.52) −7.07 (6.18) 147.45 (26.02) 148.18 (24.21) 152.67 (26.02) 153.00 (12.25)
no go juice −5.15 (4.31) −4.30 (4.07) −3.88 (5.17) −4.57 (6.00) 145.64 (31.58) 152.91 (33.98) 163.17 (29.82) 157.17 (30.04)
no go tea −5.05 (4.41) −5.47 (3.83) −4.78 (4.70) −3.98 (5.39) 150.91 (17.60) 148.73 (24.09) 148.83 (13.28) 140.17 (26.08)
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upon the occurrence of the rare beer and juice stimuli in
the Go condition (hence controlling for addiction rele-
vance), or upon the occurrence of the frequent tea
stimulus in the NoGo condition (hence controlling for
target action). While in neuroscience research NoGo
conditions constitute conditions requiring executive
control in the inhibition of actions, theories on inhib-
ition processes concentrate on networks involving sub-
cortical areas interacting with frontal brain structures
[36]. A recent study by Caharel et al. found that ampli-
tude modulations of the N170 component in a Go-
NoGo task were related to behavior only from 200 ms
onward. The N170 amplitude was found to be modu-
lated in specific task conditions, but this effect was not
related to behavior in this experiment [37]. Although
Maurage et al. recently demonstrated that executive
attention control processes are of specific relevance to
alcohol addicted patients [38], we suggest that the
observed amplitude increase in patients’ N170 compo-
nent in response to the beer stimulus under the NoGo
condition is associated with incentive salience contri-
butions to the visual processing of alcohol-related cues
in this condition. It may be that the present study
sheds no light on the exact nature of the interaction
between the addiction specific significance of the beer
stimulus and the attention control processes inherent
in the NoGo condition; but our findings may consti-
tute an argument in favor of more specifically focusing
on the processing of drug-related stimuli which have
to be ignored.
The main effect for group indicating heightened N170
ERP component amplitudes in patients regardless of
condition type may be related to the timing of the initial
assessment, which took place closely after the patients’
detoxification from alcohol. In a rat model of with-
drawal, Cheaha et al. [39] recently reported increased
gamma band power following ethanol withdrawal in rats,
and interpreted these in support of a serotonergic hypo-
function. In alcohol dependent patients, relapse was
associated with increased high frequency beta band EEG
[40]. A study by Polo et al. found increased frontal P3a
ERP amplitudes in response to NoGo stimuli among
patients abstaining from alcohol [41]. While some EEG
and ERP abnormalities have been considered as en-
dophenotypes in alcoholism [8], in our study only the
N170 amplitudes in response to the NoGo beer stimulus
were related to addiction and to the 3-month relapse
outcome. Therefore, we suggest that the heightened NoGo
N170 amplitudes in response to the beer stimulus are
specifically related to a high risk of relapse, while the
NoGo N170 amplitude main effect may be due either to
heightened post-withdrawal cortical excitability or to a
general feature of altered cortical reactivity in subjects at
risk for alcohol dependency [42].
While recent neuroimaging research has focused on
frontal and sub-cortical processing in addiction research
[43, 44], our results may be viewed as partly compatible
with recent data on cue reactivity in cocaine addicted
subjects reporting occipital BOLD activation in response
to cocaine cues, as related to relapses in patients [45].
Conversely, in the same group, those patients with high
treatment motivation exhibited lower cocaine cue reactiv-
ity in the occipital cortex regions [46]. Although another
study [47] found no connection between drug-related
occipital BOLD cue reactivity and transition to heavy
drinking, we suggest that this may be because the predict-
ive effect of drug-related cues may be confined to relapse
propensity and cues in non-target contexts. The relevance
of non-target signals for relapse is further supported by
recent animal research demonstrating increased relapse-
related behavior in rats when exposed to alcohol-related
context stimuli [48]. While the translational bridge from
conditioning experiments in rats to our study in patients
is large, this finding does suggest that non-target stimulus
contexts are relevant in understanding relapse-related
behavior in alcohol dependent patients.
Socio-demographic control variables like age, gender
and years of education did not differ between patients
and controls. The control group was recruited to match
the patients in these variables and thus, by design, the
controls in our study were not primarily recruited from
university campuses. The amount of health-related prob-
lems and the preferred kind of drinks did not differ
either, although there is some evidence to suggest that
these variables may differ in larger samples [49]. Clinical
symptoms, on the other hand, were found to be associ-
ated with addiction-related measures (AUDIT, ODCS)
and nicotine use (Fagerström). With regard to psycho-
logical symptom dimensions, impulsivity scores did not
differ significantly between patients and controls; and
did not differ between relapsing and non-relapsing
patients. Patients did, however, exhibit heightened BDI
scores as compared to controls; and the BDI scores of
relapsing patients were higher than those of non-relapsing
patients. Indeed, the BDI score differential between
relapsing and non-relapsing patients was substantial,
highly significant and reached the range of clinical
relevance [50]. This result agrees with a broad range
of evidence linking depression to relapses in the treat-
ment of alcoholism [51, 52].
In additional analyses of covariance which included
BDI scores, we aimed to assess whether heightened
depression scores may explain our main finding of
elevated N170 amplitudes under the NoGo condition, or
whether the scores otherwise interact with the ERP data.
Our results indicate that depression scores only inter-
acted with early P100 ERP results in an electrode x
stimulus x depression interaction, which is unrelated to
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the group factor. As regards the N170 component,
depression did not interact with ERP results, and the
main result of the group x condition x stimuli inter-
action was still significant in the omnibus analysis. The
lack of significant interactions in the follow-up analyses
comparing patients and controls under both task condi-
tions may be attributed to the increased complexity of
these MANCOVA analyses.
While depression did not show a significant associ-
ation with ERP amplitude data in any of the analyses,
this may be because depression is not associated with
the specific N170 ERP cue reactivity result of our study.
Depression may interact with early occipital P100 laten-
cies in patients, but overall it seems to constitute an
independent factor contributing to relapse behavior fol-
lowing alcohol detoxification. A lager study sample size
may be needed to further disentangle and differentiate
between the respective contributions made by depres-
sion and cue reactivity in occipital ERPs to relapse
behavior in detoxified alcohol patients.
Two methodological considerations should be kept in
mind when interpreting our results. The chosen sam-
pling rate of 100 Hz may be considered as sufficient to
assess the intended amplitude peaks of the P100 and the
N170 ERP components. This may, however, prohibit the
detection of small changes in latencies of ERP com-
ponent peaks. Researchers conducting a replication of
the current study may therefore wish to use a higher
sampling rate. Another methodological consideration is
our focus on one stimulus per category. Specific picture
features may have influenced the early occipital P100
component which we found between stimuli. These,
however, emerged regardless of group (patient/control)
and relapse status. Care was taken to select stimuli in a
pre-study assessment among patients with alcohol de-
pendence so as to eliminate associations between neutral
juice stimuli and alcoholic drinks; but it is possible that
some stimulus-specific parameters with effects on the
P100 have remained.
Conclusions
In conclusion, the results of our study indicate the
relevance of addiction-related stimuli in situations that
do not require directed attention for the automated
processing of alcohol-related cues. Action- related con-
trol is focused on the frequent target tea stimulus in the
NoGo condition; and while the alcohol-related stimulus
in addicted patients receives increased cortical process-
ing this may build a gap for the addiction-related stimu-
lus to be integrated into further cortical processing. This
probably induces craving which may then lead to be-
havioral changes conducive to relapse-related actions
which the patient is unprepared to voluntarily inhibit.
ERPs may reflect the propensity for addicted patients to
relapse within the first 3 months following alcohol
detoxification. Finally, our data underscore the relevance
of heightened depression symptoms for relapse risk in
patients with alcohol dependence.
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